3,380
Views
16
CrossRef citations to date
0
Altmetric
Review

Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review

&
Pages 9-21 | Received 27 Aug 2020, Accepted 19 Oct 2020, Published online: 03 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sunita  , Yogendra Singh, Gillian Beamer, Xingmin Sun & Pratyoosh Shukla. (2022) Recent developments in systems biology and genetic engineering toward design of vaccines for TB. Critical Reviews in Biotechnology 42:4, pages 532-547.
Read now

Articles from other publishers (15)

Mandana Hasanzad, Negar Sarhangi, Hamid Reza Aghaei Meybodi & Shekoufeh Nikfar. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology 467 491 .
Márcia Quinhones P. Lopes, Raquel Lima F. Teixeira, Pedro Hernan Cabello, José Augusto C. Nery, Anna Maria Sales, Edilbert Pellegrini Nahn J. R.Marilda Vieira Moreira, Ewalda Von Rosen Stahlke, Lia Gonçalves Possuelo, Maria Lucia R. Rossetti, Marcelo F. Rabahi, Luciana F. M. Silva, Patrícia Almeida Leme, William John Woods, Mauricio Lisboa Nobre, Maria Leide Wan-Del-Rey de Oliveira, Kazuê Narahashi, Milde Cavalcanti, Philip Noel Suffys, Sotiria Boukouvala, Maria Eugênia N. Gallo & Adalberto Rezende Santos. (2023) Human N-acetyltransferase 2 (NAT2) gene variability in Brazilian populations from different geographical areas. Frontiers in Pharmacology 14.
Crossref
David W. Hein, Raúl A. Salazar-González, Mark A. Doll & Yu Zang. (2023) The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposure. Archives of Toxicology 97:10, pages 2697-2705.
Crossref
Yinxia Huang, Chuanzhi Zhu, Liping Pan & Zongde Zhang. (2023) The role of Mycobacterium tuberculosis acetyltransferase and protein acetylation modifications in tuberculosis. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Carola Oelofse, Carene Anne Alene Ndong Sima, Marlo Möller & Caitlin Uren. (2023) Pharmacogenetics as part of recommended precision medicine for tuberculosis treatment in African populations: Could it be a reality?. Clinical and Translational Science 16:7, pages 1101-1112.
Crossref
Jorge E. Gutiérrez-Virgen, Maricela Piña-Pozas, Esther A. Hernández-Tobías, Lucia Taja-Chayeb, Ma. de Lourdes López-González, Marco A. Meraz-Ríos & Rocío Gómez. (2023) NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review. PLOS ONE 18:4, pages e0283726.
Crossref
Alaa Yehya. 2023. Dosage Forms - Innovation and Future Perspectives. Dosage Forms - Innovation and Future Perspectives.
Kyung U. Hong, Kennedy M. Walls & David W. Hein. (2023) Non-coding and intergenic genetic variants of human arylamine N-acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders. Frontiers in Pharmacology 14.
Crossref
Ann K. Daly. (2023) Relevance of Pharmacogenomics to the Safe Use of Antimicrobials. Antibiotics 12:3, pages 425.
Crossref
Youlin Wang, Hao Yang, Chloé Geerts, Alexandra Furtos, Paula Waters, Denis Cyr, Shupei Wang & Grant A. Mitchell. (2023) The multiple facets of acetyl-CoA metabolism: Energetics, biosynthesis, regulation, acylation and inborn errors. Molecular Genetics and Metabolism 138:1, pages 106966.
Crossref
Raúl A. Salazar-González, Mark A. Doll & David W. Hein. (2022) N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances. Archives of Toxicology 97:1, pages 189-199.
Crossref
Oswaldo Hernández-González, Diana Judith Herrera-Vargas, Miguel Ernesto Martínez-Leija, Daniel Zavala-Reyes & Diana Patricia Portales-Pérez. (2022) The role of arylamine N-acetyltransferases in chronic degenerative diseases: Their possible function in the immune system. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1869:9, pages 119297.
Crossref
Youhao Chen, Shaoxing Guan, Yanping Guan, Siyuan Tang, Yanying Zhou, Xueding Wang, Huichang Bi & Min Huang. (2022) Novel Clinical Biomarkers for Drug-Induced Liver Injury. Drug Metabolism and Disposition 50:5, pages 671-684.
Crossref
Mariana Babayeva, Brigitte Azzi & Zvi G. Loewy. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development 201 240 .
Mohammad Kalim Ahmad Khan, Salman Akhtar & Fahad Al-Khodairy. (2021) Molecular docking approach to elucidate metabolic detoxification pathway of polycyclic aromatic hydrocarbons. NeuroPharmac Journal, pages 150-161.
Crossref